D-0223-2021 Class III Terminated

Recalled by US Compounding Inc — Conway, AR

FDA drug recall D-0223-2021 was initiated by US Compounding Inc on Dec 16, 2020 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing lot and/or expiration date: The lot number and BUD were printed in the incorrect position on the product label making it illegible. The recall status is terminated (terminated Nov 5, 2021). Affected quantity: 1534 syringes.

Recall Details

Product Type
Drugs
Report Date
Jan 20, 2021
Initiation Date
Dec 16, 2020
Termination Date
Nov 5, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1534 syringes

Product Description

Succinylcholine Chloride PF Inj. 200 mg/10 mL, 10 mL single use syringes, Rx only, US Compounding, 1270 Don's Lane, Conway, AR 72032

Reason for Recall

Labeling: Incorrect or Missing lot and/or expiration date: The lot number and BUD were printed in the incorrect position on the product label making it illegible.

Distribution Pattern

USA Nationwide

Code Information

Lot #: 20202010@6 BUD: 02/17/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0223-2021
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0223-2021. Report a data issue: hello@regdatalab.com.